Quito Site

Production Site Ecuador

Our Quito site is the largest manufacturing plant for solid and semi-solid pharmaceuticals in Ecuador. It is Grünenthal’s central production facility, pharmaceutical development center and logistics hub in Latin America.

Our site in Quito is recognized as a preferred contract manufacturer throughout Latin America. Various multinational corporations are among our customers – and many of them have been with us for years. The experts in Ecuador can manufacture a variety of formulations such as granules, coated tablets, capsules, liquids, semi-solids and packaging in various blister, sachet or bottle forms.

Covering 50,000 m², the plant north of Quito guarantees Grünenthal’s high quality standards. It is certified by various Latin American authorities such as ANVISA (Brazil), INVIMA (Colombia) as well as by European authorities (covering also Cofepris, Mexico). It is one of the few facilities in Latin America licensed to export to Europe and the only one in Ecuador with an EU Good Manufacturing Practice certificate. The plant is certified according to EN ISO 14001 and ISO 45001.

Since 2025, a newly built 1,800-square-metre facility has enabled the annual production of up to 300 million high-quality tablets, serving pain patients across 17 European countries.